← all drugs
Pemetrexed Disodium Injection
being discontinued · Oncology · Snapshot: 2026-10-09
- Manufacturers listed
- Eli Lilly and Co., Sandoz Inc.
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Alimta, Injection, 500 mg/20 mL (NDC 0002-7623-01) | Eli Lilly and Co. | unknown | 10/16/2025 |
| Pemetrexed Disodium, Injection, 100 mg/4 mL (NDC 0781-3518-76) | Sandoz Inc. | unknown | 10/10/2025 |
| Alimta, Injection, 100 mg/4 mL (NDC 0002-7640-01) | Eli Lilly and Co. | unknown | 10/16/2025 |
| Pemetrexed Disodium, Injection, 500 mg/20 mL (NDC 0781-3519-90) | Sandoz Inc. | unknown | 10/10/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.